FTSE 100: GSK tops forecasts after strong sales of shingles vaccine

Published on 1 Feb 2023 on Yahoo Finance UK

GSK (GlaxoSmithKline) logo is seen in this illustration, August 10, 2022. REUTERS/Dado Ruvic/Illustration

GlaxoSmithKline has improved their forecasts for 2023 after results reveal strong sales of the pharmaceutical firm's shingles vaccine.

Read the rest of the article

Start tracking your investments with Statfolio

In this article, we discuss the 12 best biotech penny stocks to invest in. If you want to skip ou...

Insider Monkey via Yahoo Finance 24 Mar 2024

For Immediate Release Chicago, IL – March 14, 2024 – Zacks.com announces the list of stocks featu...

Zacks via Yahoo Finance 14 Mar 2024

On Mar 12, the Department of Labor reported that the consumer price index (CPI) for February incr...

Zacks via Yahoo Finance 13 Mar 2024

In this article, we discuss the 15 best drug stocks to invest in. You can skip our detailed analy...

Insider Monkey via Yahoo Finance 26 Nov 2023

GSK (GlaxoSmithKline) logo is seen in this illustration, August 10, 2022. REUTERS/Dado Ruvic/Illu...

Yahoo Finance UK 1 Feb 2023

For Immediate Release Chicago, IL – January 9, 2023 – Zacks.com announces the list of stocks feat...

Zacks via Yahoo Finance 10 Jan 2023

In this article, we will take a look at billionaire Steve Cohen's top dividend stocks. If you wan...

Insider Monkey via Yahoo Finance 19 Nov 2022

In this article, we will take a look at 12 best ethical stocks to buy now. If you want to see som...

Insider Monkey via Yahoo Finance 11 Oct 2022

AbbVie (NYSE: ABBV) and GlaxoSmithKline (NYSE: GSK) have much in common. They are huge pharmaceut...

Motley Fool 28 Sep 2022

GlaxoSmithKline (GSK) closed at $42.29 in the latest trading session, marking a +0.09% move from ...

Zacks via Yahoo Finance 18 Sep 2022